EDGAR Filing Documents for 0001628280-18-013801

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001628280-18-013801

Filing Date

2018-11-06

Accepted

2018-11-06 17:06:43

Documents

Period of Report

2018-09-30

Document Format Files

Seq	Description	Document	Type	Size
1	6-K	q3-2018x6k.htm	6-K	21883
2	EXHIBIT 99.1	q3-2018xex991fsxquarterly.htm	EX-99.1	854155
3	EXHIBIT 99.2	q3-2018xex992mdaxquarterly.htm	EX-99.2	294232
4	EXHIBIT 99.3	q3-2018xex993certification.htm	EX-99.3	12601
5	EXHIBIT 99.4	q3-2018xex994certification.htm	EX-99.4	12564
6	LOGO	aeternazentarislogoa86.jpg	GRAPHIC	14150
	Complete submission text file	0001628280-18-013801.txt		1216236

Mailing Address C/O STIKEMAN ELLIOTT LLP 1155 RENE-LEVESQUE BLVD. WEST, 41ST FLR MONTREAL A8 H3B 3V2

Business Address C/O STIKEMAN ELLIOTT LLP 1155 RENE-LEVESQUE BLVD. WEST, 41ST FLR MONTREAL A8 H3B 3V2 843-900-3201

Aeterna Zentaris Inc. (Filer) CIK: 0001113423 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38064 | Film No.: 181163871
SIC: 2834 Pharmaceutical Preparations